In recent years, the safety of traditional Chinese medicine has attracted more and more attention. Whether drugs can cause liver injury is the focus of drug safety research, it is of great significance to the development and use of traditional Chinese medicine.Immunohistochemical method can be used to localize, qualitatively and quantitatively study the antigen, and plays an important role in the study of drug hepatotoxicity.Through reviewing the reports on hepatotoxicity caused by traditional Chinese medicine and its mechanism in the past years, this paper summarizes the application of immunohistochemistry in the study of hepatotoxicity of traditional Chinese medicine, so as to provide a reference for the application of immunohistochemistry in the safety evaluation of traditional Chinese medicine.
1. 江振洲, 王欣之, 孙丽新, 等. 中药毒性评价的技术方法与应用[J]. 药学进展, 2013, 37(11): 545-554. [Jiang ZZ, Wang XZ, Sun LX, et al. Technical methods and application of traditional Chinese medicine toxicity evaluation[J]. Progress in Pharmaceutical Science, 2013, 37(11): 545-554.] http://www.cnki.com.cn/Article/CJFDTotal-YXJZ201311001.htm.
2. 彭朋, 元唯安. 中药药源性肝毒性的研究进展[J]. 药物评价研究, 2021, 44(8): 1783-1792. [Peng P, Yuan WA. Research progress on drug-induced hepatotoxicity of Chinese materia medica[J]. Drug Evaluation Research, 2021, 44(8): 1783-1792.] DOI: 10.7501/j.issn.1674-6376. 2021.08.033.
3. 李芝奇, 范琦琦, 陈美琳, 等. 中药肝毒性的物质基础与作用机制研究进展[J]. 中草药, 2021, 52(13): 4082-4095. [Li ZQ, Fan QQ, Chen ML, et al. Material basis for liver toxicity of traditional Chinese medicine and research progress on its mechanism[J]. Chinese Traditional and Herbal Drugs, 2021, 52(13): 4082-4095. ] DOI: 10.7501/j.issn.0253-2670.2021.13.032.
4. 李晓菲, 李娜, 涂灿, 等. 基于内毒素特异质模型的生首乌与制首乌肝毒性比较研究[J]. 中草药, 2015, 46(10): 1481-1486. [Li XF, Li N, Tu C, et al. Comparison of crude and prepared Polygonum multiflorum-induced idiosyncratic hepatotoxicity based on lipopolysaccharide model[J]. Chinese Traditional and Herbal Drugs, 2015, 46(10): 1481-1486.] DOI: 10.7501/j.issn.0253-2670. 2015.10.014.
5. 李梦楠, 王玉平, 周永宁. 药物性肝损伤的研究进展[J]. 胃肠病学和肝病学杂志, 2016, 25(7): 828-831. [Li MN, Wang YP, Zhou YN. Research progress of drug-induced liver injury[J]. Chinese Journal of Gastroenterology and Hepatology, 2016, 25 (7): 828-831.] DOI: 10.3969/j.issn.1006-5709.2016.07.027.
6. 郑恬, 孙志广. 中药肝损伤机制的研究进展[J]. 广西中医药, 2021, 44(4): 65-67. [Zheng T, Sun ZG. Research progress of liver injury mechanism of traditional Chinese medicine[J]. Guangxi Journal of Traditional Chinese Medicine, 2021, 44(4): 65-67.] DOI: 10.3969/j.issn. 1006-5709.2016.07.027.
7. 胡聪, 黎红维, 吴琳静, 等. 基于代谢组学的中药肝毒性研究进展[J]. 中国中药杂志, 2020, 45(11): 2493-2501. [Hu C, Li HW, Wu LJ, et al. Research progress on hepatotoxicity of traditional Chinese medicine based on metabonomics[J]. China Journal of Chinese Materia Medica, 2020, 45(11): 2493-2501.] DOI: 10.19540/j.cnki.cjcmm.20200322.201.
8. 王玉琳, 柳雨亭, 陶艳艳, 等. 以线粒体为靶点筛选中药抗肝毒性的活性成分研究思路与方法[J]. 中国中药杂志, 2021, 46(2): 306-311. [Wang YL, Liu YT, Tao YY, et al. Research ideas and method on screening active components of traditional Chinese medicine against hepatotoxicity with mitochondria as target[J]. China Journal of Chinese Materia Medica, 2021, 46(2): 306-311.] DOI: 10.19540/j.cnki.cjcmm.20200904.601.
9. 羊菲, 金若敏. 基于中药特点的肝毒性研究与思考[J]. 上海中医药大学学报, 2020, 34(1): 1-10. [Yang F, Jin RM. Research and considerations on hepatotoxicity based on characteristics of Chinese materia medica[J]. Acta Journal of Shanghai Universitatis of Traditionis Chinses Medicine, 2020, 34(1): 1-10.] DOI: 10.16306/j.1008-861x.0.2020.01.001.
10.马利节, 孔晓妮, 高月求. 中草药相关肝损伤研究进展[J]. 中西医结合肝病杂志, 2021, 31(7): 665-668. [Ma LJ, Kong XN, Gao YQ. Research progress of liver injury related to Chinese herbal medicine[J]. Chinese Journal of Integrated Traditional and Western Medicine on Liver Diseases, 2021, 31(7): 665-668.] DOI: 10.3969/j.issn.1005-0264.2021.07.025.
11.Chen YK, Tang Y, Guo CX, et al. Nuclear receptors in the multidrug resistance through the regulation of drug-metabolizing enzymes and drug transporters[J]. Biochem Pharmacol, 2012, 83(8): 1112-1126. DOI: 10.1016/j.bcp. 2012.01.030.
12.王钱, 周文静, 周荣荣, 等. 基于整合药理学逍遥散治疗雷公藤肝毒性的"中药-化学成分关键靶标-通路"的研究[J]. 中华中医药杂志, 2020, 35(1): 415-419. [Wang Q, Zhou WJ, Zhou RR, et al. Study on the 'traditional Chinese medicine-chemical component-target-pathway' of Xiaoyao Powder in the treatment of Tripterygium wilfordii hepatotoxicity based on integrated pharmacology[J]. China Journal of Traditional Chinese Medicine and Pharmacy, 2020, 35(1): 415-419.] http://www.cnki.com.cn/Article/CJFDTotal-BXYY202001111.htm.
13.李芝奇, 赵霞, 徐玥, 等. 中药肝毒性评价的现状与挑战[J]. 中华中医药杂志, 2020, 35(10): 4827-4835. [Li ZQ, Zhao X, Xu Y, et al. Current status and challenges of evaluation of hepatotoxicity of traditional Chinese medicine[J]. China Journal of Traditional Chinese Medicine and Pharmacy, 2020, 35(10): 4827-4835.] https://kns.cnki.net/KCMS/detail/detail.aspx?dbcode=CJFD&filename=BXYY202010016.
14.Zhu J, Seo JE, Wang S, et al. The development of a database for herbal and dietary supplement induced liver toxicity[J]. Int J Mol Sci, 2018, 19(10): 2955. DOI: 10.3390/ijms19102955.
15.董捷鸣, 章从恩, 于小红, 等. HMGB1介导的炎症通路在雷公藤致大鼠肝损伤中的作用研究[J]. 中国药房, 2018, 29(5): 633-636. [Dong JM, Zhang CE, Yu XH, et al. Study on the effects of HMGB1-mediated inflammatory pathway on liver injury induced by tripterygium wilfordii[J]. China Pharmacy, 2018, 29(5): 633-636.] DOI: 10.6039/j.issn.1001-0408.2018.05.14.
16.Feng Q, Yao JC, Zhou G, et al. Quantitative proteomic analysis reveals that arctigenin alleviates concanavalin A-induced hepatitis through suppressing immune system and regulating autophagy[J]. Front Immunol, 2018, 9: 1881. DOI: 10.3389/fimmu.2018.01881.
17.Zhou YQ, Weng XF, Dou R, et al. Betulin from Hedyotishedyotidea ameliorates concanavalin A-induced and T cell-mediated autoimmune hepatitis in mice[J]. Acta Pharmacol Sin, 2017, 38(2): 201-210. DOI: 10.1038/aps.2016.102.
18.贺兰芝, 尹萍, 孟雅坤, 等. PPAR-γ依赖的何首乌免疫性特异质肝损伤机制研究[J]. 药学学报, 2017, 52(7): 1027-1032. [He LZ, Yin P, Meng YK, et al. Study on the mechanism of PPAR-γ dependent immunological idiosyncrasy liver injury induced by Polygonum multiflorum[J]. Acta Pharmaceutica Sinica, 2017, 52(7): 1027-1032.] DOI: 10.16438/j.0513-4870.2016-0774.
19.桂蜀华, 王贵均, 熊艺花, 等. 狭基线纹香茶菜对免疫性肝损伤小鼠TNF-α mRNA和蛋白表达水平的影响[J]. 中药药理与临床, 2011, 27(4): 43-46. [Gui SH, Wang GJ, Xiong YH, et al. Study on TNF-α mRNA and protein expression in mice with immune injury treated by water-soluble extract from Isodon lophanthoides var.gerardianus (Benth) Har[J]. Pharmacology and Clinics of Chinese Materia Medica, 2011, 27(4): 43-46.] DOI: 10.13412/j.cnki.zyyl.2011.04.026.
20.桂蜀华, 常金荣, 梁远园, 等. 狭基线纹香茶菜水提部位对免疫肝损伤小鼠NF-κB蛋白表达水平及核转位的影响[J]. 中国药房, 2011, 22(11): 980-982. [Gui SH, Chang JR, Liang YY, et al. The effect of water extract from Rabdosia striata on NF in mice with immune liver injury-κ effect of B protein expression level and nuclear translocation[J]. China Pharmacy, 2011, 22(11): 980-982.] http://www.cnki.com.cn/Article/CJFDTotal-ZGYA201111011.htm.
21.钱卫斌, 钱秋海. 糖肝康对TAA致糖尿病模型大鼠肝损伤肝脏TLR4表达的影响[J]. 中国药理学通报, 2016, 32(2): 295-296. [Qian WB, Qian QH. Effect of Tanggankang on immunohistochemical expression of TLR4 in acute damaged liver rat model[J]. Chinese Pharmacological Bulletin, 2016, 32(2): 295-296.] DOI: 10.3969/j.issn.1001-1978.2016.02.030.
22.张玉蓉, 汪静, 朱晓宁, 等. 祛痰活血方调控LPS介导TLR4/Myd88/NF-κB信号通路抗NASH大鼠肝损伤的机制研究[J]. 四川中医, 2021, 39(8): 34-38. [Zhang YR, Wang J, Zhu XN, et al. Mechanism of Qutan Huoxue Formula on LPS-mediated TLR4/Myd88/NF-κB signaling pathway against jury for NASH rats[J]. Journal of Sichuan of Traditional Chinese Medicine, 2021, 39(8): 34-38.] DOI: 1000-3649(2021)08-0034-05.
23.唐双意, 王希斌, 丘岳西, 等. 罗莫司对肝脏热缺血-再灌注损伤小鼠肝组织TLR4表达和细胞自噬功能的影响[J]. 实用肝脏病杂志, 2021, 24(5): 669-672. [Tang SY, Wang XB, Qiu YX, et al. Effects of sirolimus on hepatic TLR4 expression and autophagy in mice with partial hepatic warm ischemia-reperfusion injury[J]. Journal of Practical Hepatology, 2021, 24(5): 669-672.] DOI: 10.3969/j.issn.1672-5069.2021.05.016.
24.Ma X, Peng JH, Hu YY. Chinese herbal medicine-induced liver injury[J]. J Clin Transl Hepatol, 2014, 2(3): 170. DOI: 10.14218/JCTH.2014.00009.
25.侯健, 孙娥, 宋捷, 等. 肝脏药物代谢酶CYP450与中药肝毒性的关系[J]. 中国中药杂志, 2016, 41(15): 2774-2780. [Hou J, Sun E, Song J, et al. Relationship between hepatic drug-metabolizing enzymes CYP450 and traditional Chinese medicine-induced hepatotoxicity[J]. China Journal of Chinese Materia Medica, 2016, 41(15): 2774-2780.] DOI: 10.4268/cjcmm20161505.
26.Abd-Elhakim YM, Moustafa GG, El-Sharkawy NI, et al. The ameliorative effect of curcumin on hepatic CYP1A1 and CYP1A2 genes dysregulation and hepatorenal damage induced by fenitrothion oral intoxication in male rats[J]. Pestic Biochem Physiol, 2021, 179:104959. DOI: 10.1016/j.pestbp.2021.104959.
27.Braeuning A, Schwarz M. Regulation of expression of drug-metabolizing enzymes by oncogenic signaling pathways in liver tumors: a review [J]. Acta Pharm Sin B, 2020, 10(1): 113-122. DOI: 10.1016/j.apsb.2019.06.013.
28.时乐, 徐立. 黄药子总皂苷致肝损伤与CYP450的相关性研究[A]//全国有毒中药的研究及其合理应用交流研讨会[C]. 北京:中华中医药学会, 2012.
29.Lu Y, Xie T, Zhang Y, et al. Triptolide induces hepatotoxicity via inhibition of CYP450s in rat liver microsomes[J]. BMC Complement Altern Med, 2017, 17(1): 15. DOI: 10.1186/s12906-016-1504-3.
30.程敏, 汤俊. 菊三七中吡咯里西啶类化学成分及其药理毒理作用的研究进展[J]. 中国药师, 2018, 21(12): 2206-2210. [Chen M, Tang J. Research progress in pyrrolizidine alkaloids and their pharmacological and toxicological effects from Gy-nurae Japonicae Rhizoma seu herba[J]. China Pharmacist, 2018, 21(12): 2206-2210.] DOI: 10.3969/j.issn.1008-049X.2018.12.031.
31.杨新华, 夏宏光, 金涌. 雷公藤甲素通过抑制细胞色素P450 3A4酶增强肝损伤研究[J]. 安徽医科大学学报, 2020, 55(4): 496-502. [Yang XH, Xia HG, Jin Y. Triptolide enhances liver injury by inhibiting its metabolic enzyme cytochrome P450 3A4[J]. Acta Universitatis Medicinalis Anhui, 2020, 55(4): 496-502.] DOI: 10.19405/j.cnki.issn1000-1492.2020.04.003.
32.华碧春, 刘娇, 黄智锋, 等. 黄药子配伍甘草对大鼠肝脏CYP1A2、CYP2E1蛋白表达影响的实验研究[J]. 中药与临床, 2014, 5(5): 29-31. [Hua BC, Liu J, Huang ZF, et al. Experimental study on CYP1A2 and CYP2E1 protein expression in liver of rats by combined administration of Huangyaozi and Gancao[J]. Pharmacy and Clinics of Chinese Materia Medica, 2014, 5(5): 29-31.] DOI: CNKI:SUN:LCZY.0.2014-05-011.
33.刘娇. 黄药子配伍甘草对氧化应激及大鼠肝脏CYP1A2、CYP2E1蛋白表达影响的研究[D]. 福州:福建中医药大学, 2014.
34.陈鑫, 葛芹, 张彩云, 等. 异甘草酸镁对CCl4致急性肝损伤大鼠肝组织CYP1A2、CYP2E1蛋白及其mRNA表达的影响[J]. 安徽中医药大学学报, 2017, 36(1): 55-58. [Chen X, Ge Q, Zhang CY, et al. Influence of magnesium isoglycyrrhizinate on protein and mRNA expression of CYP1A2 and CYP2E1 in liver tissues in rats with acute liver injury induced by carbon tetrachloride[J]. Journal of Anhui University of Chinese Medicine, 2017, 36(1): 55-58.] DOI: 10.3969/j.issn.2095-7246.2017.01.017.
35.王君明, 崔瑛, 申玲玲, 等. 中药致药源性肝损伤的氧化应激机制研究进展[J]. 中国实验方剂学杂志, 2011, 17(5): 247-249. [Wang JM, Cui Y, Shen LL, et al. Research progress in mechanism based on oxidative stress of liver injury induced by Chinese medicine[J]. China Journal of Experimental Traditional Medical Formulae, 2011, 17(5): 247-249.] DOI: 10.3969/j.issn.1005-9903.2011.05.077.
36.Li XY, Li X, Lu JX, et al. Saikosaponins induced hepatotoxicity in mice via lipid metabolism dysregulation and oxidative stress: a proteomic study[J]. BMC Complement Altern Med, 2017, 17(1): 219. DOI: 10.1186/s12906-017-1733-0.
37.Lee AY, Jang Y, Hong SH, et al. Ephedrine-induced mitophagy via oxidative stress in human hepatic stellate cells[J]. J Toxicol Sci, 2017, 42(4): 461-473. DOI: 10.2131/jts.42.461.
38.李逸群, 刘春芳, 贾可欣, 等. 6个不同厂家雷公藤多苷片大剂量致正常大鼠慢性多脏器损伤的比较研究[J]. 中国中药杂志, 2020, 45(4): 746-754. [Li YQ, Liu CF, Jia KX, et al. Comparative study on chronic multiple organ injury in normal rats caused by high dose of Tripterygium Glycosides Tablets from 6 different manufacturers[J]. China Journal of Chinese Materia Medica, 2020, 45(4): 746-754.] DOI: 10.19540/j.cnki.cjcmm.20191017.401.
39.牛成伟, 陆宾, 季莉莉, 等. 黄独素B诱导小鼠急性肝损伤及其机制[J]. 中国中药杂志, 2014, 39(7): 1290-1292. [Niu CW, Lu B, Ji LL, et al. Acute liver injury induced by Huangdu B in mice and its mechanism[J]. China Journal of Chinese Materia Medica, 2014, 39(7): 1290-1292.] DOI: CNKI:SUN:ZGZY.0.2014-07-030.
40.You L, Yang C, Du Y, et al. Matrine exerts hepatotoxic effects via the ROS-dependent mitochondrial apoptosis pathway and inhibition of Nrf2-mediated antioxidant response[J]. Oxid Med Cell Longev, 2019, 2019: 1045345. DOI: 10.1155/2019/1045345.
41.何茂群, 曹智华, 苗得足. Nrf2信号通路及其在肝组织中的作用[J]. 药学进展, 2014, 38(4): 257-263. [He MQ, Cao ZH, Miao DZ. Nrf2 signaling pathway and its function in hepatic tissue[J]. Progress in Pharmaceutical Sciences, 2014, 38(4): 257-263.] DOI: CNKI:SUN:YXJZ.0.2014-04-004.
42.Wei X, Wang H, Sun X, et al. 4-hydroxy-2(3H)-benzoxazolone alleviates acetaminophen induced hepatic injury by inhibiting NF-κB and activating Nrf2/HO-1 signaling pathways[J]. Am J Transl Res, 2020, 12(5): 2169-2180. https://pubmed.ncbi.nlm.nih.gov/32509209/.
43.张雨淼, 胡珊, 陈龙, 等. 4-PBA通过Nrf2/NQO1通路减轻急性汞中毒小鼠肝氧化应激和功能损伤[J]. 中国组织化学与细胞化学杂志, 2021, 30(4): 330-334. [Zhang YM, Hu S, Chen L, et al. 4-PBA reduces acute mercury poisoning mice liver injury by oxidative stress through Nrf2/NQO1 pathway[J]. Chinese Journal of Histochemistry and Cytochemistry, 2021, 30(4): 330-334.] DOI: 10.16705/j.cnki.1004-1850.2021.04.004.
44.胡勇, 姚茂琳, 于春, 等. 银杏叶片调控Nrf2-Keap1-ARE信号通路改善燃煤污染型地方性砷中毒大鼠肝损伤的作用[J]. 中华地方病学杂志, 2021, 40(6): 441-447. [Hu Y, Yao ML, Yu C, et al. Ginkgo biloba regulate Nrf2-Keap1-ARE signaling pathway to ameliorate liver injury in endemic arsenic poisoning rats induced by coal burning[J]. Chinese Jouranl of Endemiology, 2021, 40(6): 441-447.] DOI: 10.3760/cma.j.cn231583-20201022-00273.
45.屈丹丹, 彭福江, 刘莉, 等. 臭氧化盐水对肝细胞Keap1-Nrf2-ARE通路的激活作用[J]. 中华肝脏病杂志, 2011, 19(5): 367-371. [Qu DD, Peng FJ, Liu L, et al. Effect of ozonized saline on signaling passway of Keap1-Nrf2-ARE in rat hepatocytes[J]. Chinese Journal of Hepatology, 2011, 19(5): 367-371.] DOI: 10.3760/cma.j.issn.1007-3418.2011.05.013.
46.杨亚维, 袁杰. PPARα抗氧化应激作用的研究进展[J]. 东南大学学报, 2016, 35(1): 147-150. [Yang YW, Yuan J. PPARα research progress of antioxidant stress[J]. Journal of Southeast University, 2016, 35(1): 147-150.] DOI: 10.3969/j.issn.1671-6264.2016.01.034.
47.张安民, 徐燕, 谷伯起, 等. 小鼠谷胱甘肽过氧化物酶分布的免疫组化研究[J]. 中国组织化学与细胞化学杂志, 1993, (2): 152-155. [Zhang AM, Xu Y, Gu BQ, et al. Immunohistochemical localization of glutathione peroxidase in mice tessues[J]. Chinese Journal of Histochemistry and Cytochemistry, 1993, (2): 152-155.] DOI: CNKI:SUN:GGZZ.0.1993-02-013.
48.胡勇, 王蕾, 王胜利, 等. Nrf2-Keap1-ARE信号通路在燃煤型砷中毒大鼠肝损伤中的作用[J]. 环境与健康杂志, 2020, 37(2): 100-105. [Hu Y, Wang L, Wang SL, et al. Role of Nrf2-Keap1-ARE signaling pathway in liver injury in rats with coal-burning-induced arsenism[J]. Journal of Environment and Health, 2020, 37(2): 100-105.] DOI: 10.16241/j.cnki.1001-5914.2020.02.002.
49.张韫, 赵宗江, 李平, 等. 黄连素对2型糖尿病大鼠肝脏Nrf2介导的氧化应激反应的影响[J]. 中华中医药杂志, 2020, 35(1): 150-154. [Zhang Y, Zhao ZJ, Li P, et al. Effects of berberine on Nrf2 mediated oxidative stress in liver of type 2 diabetic rats[J]. China Journal of Traditional Chinese Medicine and Pharmacy, 2020, 35(1): 150-154.] DOI: CNKI:SUN:BXYY.0.2020-01-036.
50.刘芳, 王玉珍, 赵世敏, 等. 沙棘多糖对急性肝损伤小鼠氧化应激的抑制作用及其对BCL-2/Bax和PPAR-γ的调控[J]. 中国免疫学杂志, 2016, 32(3): 358-361. [Liu F, Wang YZ, Zhao SM, et al. Inhibitory effects of seabuckthorn polysaccharide on oxidative stress in mice with actue liver injury and modulatory effect on BCL-2/Bax and PPAR-γexpression[J]. Chinese Journal of Immunology, 2016, 32(3): 358-361.] DOI: 10.3969/j.issn.1000-484X.2016.03.014.
51.宋琬晨, 郭婉霜, 郑伟娟. 大黄素型蒽醌类化合物肝肾毒性的分子机制研究[J]. 药物生物技术, 2020, 27(2): 149-153. [Song WC, Guo WS, Zheng WJ. Study on the molecular mechanism of hepatorenal toxicity of emodin-type anthraquinone compounds[J]. Chinese Journal of Pharmaceutical Biotechnology, 2020, 27(2): 149-153.] DOI: 10.19526/j.cnki.1005-8915.20200212.
52.张辉艳, 张绪清. 糖皮质激素阻止肝衰竭发生与发展的机制[J]. 胃肠病学和肝病学杂志, 2016, 25(5): 481-484. [Zhang HY, Zhang XQ. Mechanisms of glucocorticoids in preventing the development and progress of liver failure[J]. Chinese Journal of Gastroenterology and Hepatology, 2016, 25 (5): 481-484.] DOI: 10.3969/j.issn.1006-5709.2016.05.001.
53.Liu Y, Dong X, Wang W, et al. Molecular mechanisms of apoptosis in HepaRG cell line induced by polyphyllin VI via the fas death pathway and mitochondrial-dependent pathway[J]. Toxins, 2018, 10(5): 201. DOI: 10.3390/toxins10050201.
54.王海颖, 张晋军, 张艳敏, 等. 芍药红花煎剂对肝损伤细胞氧自由基及凋亡因子影响研究[J]. 中华中医药学刊, 2016, 34(6): 1348-1350. [Wang HY, Zhang JJ, Zhang YM, et al. Shaoyao honghua decoction on oxygen free radical and apoptosis factors of liver injury[J]. Chinese Archives of Traditional Chinese Medicine, 2016, 34(6): 1348-1350.] DOI: 10.13193/j.issn.1673- 7717.2016.06.018.
55.廖纬琳, 陈国忠, 苏洪佳, 等. 七方胃痛颗粒对胃癌细胞中Fas /FasL通路的影响[J]. 时珍国医国药, 2018, 29(8): 1804-1807. [Liao WL, Chen GZ, Su HJ, et al. Effect of Qifang Weitong granule on Fas/Fasl pathway in gastric cancer cells[J]. Lishizhen Medicine and Materia Medica Research, 2018, 29(8): 1804-1807.] DOI: CNKI:SUN:SZGY.0.2018-08-004.
56.郭存丽, 毕玉美, 刘钊, 等. 肝细胞肝癌患者外周血CD8+T淋巴细胞凋亡相关机制探讨[J]. 现代肿瘤医学, 2018, 26(14) : 2151-2155. [Guo CL, Bi YM, Liu Z, et al. The related mechanism of CD8+T lymphocyte apoptosis in patients with hepatocellular carcinoma[J]. Journal of Modern Oncology, 2018, 26(14) : 2151-2155.] DOI: 10.3969/j.issn.1672-4992.2018.14.003.
57.霍亮, 骆杨, 许家亮. 肝细胞癌中Ki-67和FasL的表达关系及临床意义[J]. 肝脏, 2018, 23(12): 1119-1123. [Huo L, Luo Y, Xu JL. Expression of Ki-67 and FasL in hepatocellular carcinoma and its clinical significance[J]. Chinese Hepatology, 2018, 23(12): 1119-1123.] DOI: CNKI:SUN:ZUAN.0.2018-12-023.
58.刘俊红, 朱平生, 朱正望, 等. 扶正祛邪方抗ConA模型小鼠肝损伤的作用机制[J]. 中国实验方剂学杂志, 2019, 25(20): 70-75. [Liu JH, Zhu PS, Zhu ZW, et al. Mechanism of fuzheng quxie prescription against liver injury of cona model mice[J]. Chinese Journal of Experimental Traditional Medical Formulae, 2019, 25(20): 70-75. ] DOI: 10.13422/j.cnki.syfjx.20192040.
59.王洁, 张佳信, 叶新苗, 等. 基于Fas/FasL信号通路探讨太旨颗粒对非酒精性脂肪肝大鼠的保护作用及机制研究[J]. 中华中医药杂志, 2020, 35(8): 4214-4217 [Wang J, Zhang JX, Ye XM, et al. Study on protective effect and mechanism of Taizhi Granules on nonalcoholic fatty liver rats based on Fas/FasL signaling pathway[J]. China Journal of Traditional Chinese Medicine and Pharmacy, 2020, 35(8): 4214-4217.] http://qikan.cqvip.com/Qikan/Article/Detail?id=7103034352.
60.栾玉泉, 徐立, 王成军. 葛根提取物对酒精性肝损伤大鼠肝组织TNF-α表达变化的研究[J]. 大理学院学报, 2009, 8(2): 1-4. [Luan YQ, Xu L, Wang CJ. On the expressive changes of the rat's alcoholic liver injury 's TNF-α caused by the extractive from the root of Kudzu vine[J]. Journal of Dali University, 2009, 8(2): 1-4.] DOI: 10.3969/j.issn.1672-2345.2009.02.001.
61.Ron D, Walter P. Signal integration in the endoplasmic reticulum unfolded protein response[J]. Nat Rev Mol Cell Biol, 2007, 8(7): 519-529. DOI: 10.1038/nrm2199.
62.Ozcan L, Tabas I. Role of endoplasmic reticulum stress in metabolic disease and other disorders[J]. Annu Rev Med, 2012, 63: 317-328. DOI: 10.1146/annurev-med-043010-144749.
63.Shen Z, Chen J, Lu H. Osthole induced apoptosis in human normal liver cells by regulating cell proliferation and endoplasmic reticulum stress[J]. Environ Toxicol, 2019, 34(6): 768-776. DOI: 10.1002/tox.22743.
64.彭馨仪, 罗新华. 内质网应激蛋白CHOP、Caspase-12在药物性肝损伤大鼠肝组织中的表达变化及作用研究[J]. 贵州医药, 2019, 43(2): 174-177. [Peng XY, Luo XH. Study on the expression and role of endoplasmic reticulum stress proteins CHOP and Caspase-12 in liver tissue of rats with drug-induced liver injury[J]. Guizhou Medical Journal, 2019, 43(2): 174-177.] DOI: 10.3969/j.issn.1000-744X.2019.02.002.
65.Lu H, Zhang L, Gu LL, et al. Oxymatrine induces liver injury through JNK signalling pathway mediated by TNF α in vivo[J]. Basic Clin Pharmacol Toxicol, 2016 119(4):405-411. DOI: 10.1111/bcpt.12608.
66.赵亚飞, 高杨, 吴欣芳, 等. 蚯蚓活性组分对四氯化碳诱导小鼠内质网应激所致急性肝损伤的保护作用[J]. 中国中药杂志, 2017, 42(6): 1183-1188. [Zhao YF, Gao Y, Wu XF, et al. Protective effect of earthworm active ingredientsagainst endoplasmic reticulum stress-induced acute liver injury in mice[J]. China Journal of Chinese Materia Medica, 2017, 42(6): 1183-1188.] DOI: 10.19540/j.cnki.cjcmm.20170121.028.
67.吕行直, 李瑞芳, 高子涵, 等. 柴胡皂苷-b2抑制内质网应激信号通路减轻四氯化碳致小鼠急性肝损伤[J]. 中国药理学与毒理学杂志, 2019, 33(2): 109-115. [Lyu XZ, Li RF, Gao ZH, et al. Saikosaponin-b2 alleviates CCl4-induced acute liver injury in mice by inhibiting endoplasmic reticulum stress signal pathway[J]. Chinese Journal of Pharmacology and Toxicology, 2019, 33(2): 109-115.] DOI: 10.3867/j.issn.1000-3002.2019.02.004.
68.胡珊, 张雨淼, 王保强, 等. 内质网应激介导小鼠急性汞中毒性肝损伤[J]. 中国组织化学与细胞化学杂志, 2021, 30(2): 115-120. [Hu S, Zhang YM, Wang BQ, et al. Endoplasmic reticulum stress mediates acute mercury poisoning induced liver injury in mice[J]. Chinese Journal of Histochemistry and Cytochemistry, 2021, 30(2): 115-120.] DOI: 10.16705/j.cnki.1004-1850.2021.02.001.
69.魏海梁, 司明明, 郭辉, 等. 线粒体与肝细胞损伤的关系[J]. 临床肝胆病杂志, 2020, 36(3): 687-689. [Wei HL, Si MM, Guo H, et al. Association between mitochondria and hepatocellular injury[J]. Journal of Clinical Hepatol, 2020, 36(3): 687-689.] DOI: 10.3969/j.issn.1001-5256.2020.03.048.
70.周兴, 李雪梅, 李晓辉. 以线粒体为靶点治疗肝损伤的研究进展[J]. 重庆理工大学学报, 2021, 35(9): 184-193. [Zhou X, Li XM, Li XH. Research progress in the treatment of liver injury by targeting mitochondria[J]. Journal of Chongqing University of Technology, 2021, 35(9): 184-193.] DOI: 10.3969/j.issn.1674-8425(z).2021.09.023.
71.郭家彬, 彭辉, 王以美, 等. 线粒体毒性评价及其在创新药物安全性评价中的意义[J]. 中国新药杂志, 2012, 21(16): 1867-1871. [Guo JB, Peng H, Wang YM, et al. Significance of mitochondrial toxicity testing in the safety evaluation of innovative drugs[J]. Chinese Journal of New Drugs, 2012, 21(16): 1867-1871. ] https://d.wanfangdata.com.cn/periodical/zgxyzz201216008.
72.Pan YX, Luo Z, Zhuo MQ, et al. Oxidative stress and mitochondrial dysfunction mediated Cd-induced hepatic lipid accumulation in zebrafish Danio rerio[J]. Aquat Toxicol, 2018, 199: 12-20. DOI: 10.1016/j.aquatox.2018.03.017.
73.陈廷玉, 陈大印, 谢金鹿, 等. Nrf2/ARE信号通路在槲皮素抑制异烟肼诱导的肝细胞线粒体氧化损伤中的作用[J]. 癌变.畸变.突变, 2021, 33(3): 208-212,217. [Chen TY, Chen DY, Xie JL, et al. Role of the Nrf2/ARE signaling pathway on quercetin-inhibition of INH-induced mitochondrial oxidative damage in hepatocytes[J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2021, 33(3): 208-212, 217.] DOI: 10.3969/j.issn.1004-616x. 2021.03.009.
74.Chen CH, Chen MF, Huang SJ, et al. Saikosaponin a induces apoptosis through mitochondria-dependent pathway in hepatic stellate cells[J]. Am J Chin Med, 2017, 45(2): 351-368. DOI: 10.1142/S0192415X17500227.
75.连闻雨, 杨春启, 林毅, 等. 黄连碱通过线粒体损伤及内质网应激PERK-ATF4-CHOP通路导致L02细胞毒性[J]. 军事医学, 2021, 45(11): 834-842. [Lian WY, Yang CQ, Lin Y, et al. Cytotoxicity of coptisine via endoplasmic reticulum stress PERK -ATF4-CHOP pathway and mitochondrial damage pathway in L02 cells[J]. Military Medical Sciences, 2021, 45(11): 834-842.] DOI: 10.7644/j.issn.1674-9960.2021.11.008.
76.王加志, 刘树民, 赵艳, 等. 黄药子中二萜内酯类成分对大鼠肝细胞损伤作用的实验研究[J]. 药物不良反应杂志, 2009, 11(1): 13-16. [Wang JZ, Liu SM, Zhao Y, et al. Experimental studies on liver cell injury induced by diterpene lactones extracted from Dioscorea bulbifera[J]. Adverse Drug Reactions Journal, 2009, 11(1): 13-16.] DOI: 10.3969/j.issn.1008-5734.2009.01.004.
77.Yang X, Wang H, Ni HM, et al. Inhibition of Drp1 protects against senecionine induced mitochondriamediated apoptosis in primary hepatocytes and in mice[J]. Redox Biol, 2017, 12: 264-273. DOI: 10.1016/j.redox.2017. 02.020.
78.赵莉萍, 梅俏, 胡咏梅, 等. 一氧化氮在双氯芬酸钠致大鼠急性肝损伤中的作用[J]. 中国药理学与毒理学杂志, 2013, 27(5): 836-841. [Zhao LP, Mei Q, Hu YM, et al. Role of nitric oxide in rats with acute liver injury induced by diclofenac[J]. Chinese Journal of Pharmacology and Toxicology, 2013, 27(5): 836-841. ] DOI: 10.3867/j.issn.1000-3002.2013.05.012.
79.靖国庆, 吴云, 孟庆涛, 等. 羟考酮预处理对大鼠肠缺血再灌注时线粒体途径肝细胞凋亡的影响[J]. 中华麻醉学杂志, 2018, 38(6): 672-675. [Jing GQ, Wu Y, Meng QT, et al. Effect of oxycodone preconditioning on mitochondrion-dependent apoptosis in liver cells during intestinal ischemia-reperfusion in rats[J]. Chinese Journal of Anesthesiology, 2018, 38(6): 672-675.] DOI: 10.3760/cma.j.issn.0254-1416.2018.06.009.
80.宣文婷, 卢昕奕, 李俊. 丙泊酚通过影响SIRT2调控线粒体自噬对酒精性肝损伤的保护作用[J]. 中国药理学通报, 2021, 37(11): 1512-1518. [Xuan XT, Lu XY, Li J. Propofol protects against alcohol-induced liver injury to up-regulate mitophagy via SIRT2[J]. Chinese Pharmacological Bulletin, 2021, 37(11): 1512-1518. ] DOI: 10.3969/j.issn.1001-1978.2021.11.007.
81.康敏, 李森, 钟德君, 等. 非酒精性脂肪肝大鼠肝细胞凋亡与线粒体膜通透性转换孔开放的关系[J]. 南方医科大学学报, 2013, 33(7): 1062-1066. [Kang M, Li S, Zhong DJ, et al. Hepatocyte apoptosis and mitochondrial permeability transition pore opening in rats with nonalcoholic fatty liver[J]. Journal of Southern Medical University, 2013, 33(7): 1062-1066. ] DOI: 10.3969/j.issn.1673-4254.2013.07.26.